CBNPC 1ère ligne : place de la gemcitabineBARATA, Daprès F.Revue de pneumologie clinique (Paris). 2005, Vol 61, Num 4, pp 4S20-4S22, issn 0761-8417, CAH2Article

Gemcitabine and cisplatin in refractory malignant lymphomaAVILES, Agustin; NERI, Natividad; HUERTA-GUZMAN, Judith et al.Oncology. 2004, Vol 66, Num 3, pp 197-200, issn 0030-2414, 4 p.Article

Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine modelsBIN YAO; HE, Qiu-Ming; CHENG, Xian-Cheng et al.Human gene therapy. 2005, Vol 16, Num 9, pp 1075-1086, issn 1043-0342, 12 p.Article

EGFR mutations as a predictive marker of cytotoxic chemotherapyJIN HYUN PARKA; LEE, Se-Hoon; KEAM, Bhumsuk et al.Lung cancer. 2012, Vol 77, Num 2, pp 433-437, issn 0169-5002, 5 p.Article

Intravesical gemcitabine: A phase 1 and pharmacokinetic studyWITJES, J. A; VAN DER HEIJDEN, A. G; VRIESEMA, J. L. J et al.European urology. 2004, Vol 45, Num 2, pp 182-186, issn 0302-2838, 5 p.Article

Métastases choroïdiennes révélatrices d'un adénocarcinome bronchique et involuant sous chimiothérapie = Choroid metastases revealing pulmonary adenocarcioma resolved with chemotherapyBATTIKH, M. H; BEN YAHIA, S; BEN SAYAH, M. M et al.Revue de pneumologie clinique (Paris). 2004, Vol 60, Num 6, pp 353-356, issn 0761-8417, 4 p., CAH1Article

Synthesis of gemcitabine triphosphate (dFdCTP) as a tris(triethylammonium) saltRISBOOD, Prabhakar A; KANE, Charles T; TAFAZZAL HOSSAIN, Md et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 9, pp 2957-2958, issn 0960-894X, 2 p.Article

Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugsBRUSA, Paola; IMMORDINO, Maria Laura; ROCCO, Flavio et al.Anticancer research. 2007, Vol 27, Num 1A, pp 195-199, issn 0250-7005, 5 p.Article

Does saturable formation of gemcitabine triphosphate occur in patients?THAM, Lai-San; WANG, Ling-Zhi; SOO, Ross A et al.Cancer chemotherapy and pharmacology. 2008, Vol 63, Num 1, pp 55-64, issn 0344-5704, 10 p.Article

Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgeryPANDIAN, Zabeena; SECKL, Michael J; SMITH, Richard et al.BJOG (Oxford. Print). 2004, Vol 111, Num 4, pp 382-384, issn 1470-0328, 3 p.Article

Interaction of lipophilic gemcitabine prodrugs with biomembrane models studied by Langmuir-Blodgett techniqueCASTELLI, Francesco; GRAZIA SARPIETRO, Maria; ROCCO, Flavio et al.Journal of colloid and interface science. 2007, Vol 313, Num 1, pp 363-368, issn 0021-9797, 6 p.Article

Gemcitabine, paclitaxel, and piritrexim: A phase I studyLIU, Glenn; BAILEY, Howard H; ARZOOMANIAN, Rhoda Z et al.American journal of clinical oncology. 2003, Vol 26, Num 3, pp 280-284, issn 0277-3732, 5 p.Article

A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia typesHARIVARDHAN REDDY, L; DUBEMET, Catherine; LEPETRE MOUELHI, Sinda et al.Journal of controlled release. 2007, Vol 124, Num 1-2, pp 20-27, issn 0168-3659, 8 p.Article

Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanismsGUJAR, S. A; CLEMENTS, D; DIELSCHNEIDER, R et al.British journal of cancer. 2014, Vol 110, Num 1, pp 83-93, issn 0007-0920, 11 p.Article

The role of apoptotic cell death in the radiosensitising effect of gemcitabinePAUWELS, B; VERMORKEN, J. B; WOUTERS, A et al.British journal of cancer. 2009, Vol 101, Num 4, pp 628-636, issn 0007-0920, 9 p.Article

Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulationMERCIER, Cédric; RAYNAL, Caroline; SALAS, Sebastien et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 10, pp 841-844, issn 1744-6872, 4 p.Article

Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreasPLATE, Janet M. D; PLATE, Aileen E; SHOTT, Susan et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 9, pp 915-925, issn 0340-7004, 11 p.Article

Aerosol delivery of chemotherapy in an orthotopic model of lung cancerGAGNADOUX, F; PAPE, A. L; LEMARIE, E et al.The European respiratory journal. 2005, Vol 26, Num 4, pp 657-661, issn 0903-1936, 5 p.Article

Pharmacokinetics and metabolism of SL-01, a prodrug of gemcitabine, in ratsCUIRONG ZHAO; YUANYUAN LI; YIZHUO QIN et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 6, pp 1541-1550, issn 0344-5704, 10 p.Article

Clinical pharmacology and pharmacogenetics of gemcitabineWONG, Andrea; SOO, Ross A; YONG, Wei-Peng et al.Drug metabolism reviews (Softcover ed.). 2009, Vol 41, Num 2, pp 77-88, issn 0360-2532, 12 p.Article

Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsulesSTELLA, Barbara; ARPICCO, Silvia; ROCCO, Flavio et al.International journal of pharmaceutics. 2007, Vol 344, Num 1-2, pp 71-77, issn 0378-5173, 7 p.Conference Paper

Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancerTIEN HOANG; KIM, Kyungmann; JASLOWSKI, Anthony et al.Lung cancer. 2003, Vol 42, Num 1, pp 97-102, issn 0169-5002, 6 p.Article

Gemcitabine-induced respiratory failure associated with elevated erythrocyte sedimentation rate (ESR)DAVIDOFF, Sam; SHAH, Rakesh D; ARUNABH, Talwar et al.Respiratory medicine. 2006, Vol 100, Num 4, pp 760-763, issn 0954-6111, 4 p.Article

In vitro genotoxic effects of the anticancer drug gemcitabine in human lymphocytesAYDEMIR, Nilüfer; CELIKLER, Serap; BILALOGLU, Rahmi et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2005, Vol 582, Num 1-2, pp 35-41, issn 1383-5718, 7 p.Article

Mésothéliome pleural : actualités en chimiothérapie = Mesothelioma : advances in chemotherapyJACOULET, P.Revue des maladies respiratoires. 2005, Vol 22, Num 6, pp 8S49-8S54, issn 0761-8425, CAH2Conference Paper